The antiplatelet and anticoagulant activity of 7-O-gentiobiozide formononetin in vitro and in vivo
https://doi.org/10.20538/1682-0363-2016-4-30-39
Abstract
Aim. In experiments in vitro and in vivo it was investigated the effect of isoflavone 7-O-gentiobiozide formononetin (GBF) isolated from the roots of the plant Maackia аmurensis (Maackia amurensis Rupr. et Maxim.), on the processes of vascular-platelet and coagulation hemostasis.
Materials and methods. In experiments using blood of healthy human plasma in concentrations of GBF 1,0–50,0 mM promoted dose-dependently ADP-induced weakening of platelet aggregation. Since the concentration of 10,0 mM GBF induced hypocoagulative changes in blood plasma, comparable with the effect of 0,2–0,5 IU/ml heparin. Revealed hypocoagulative effect was confirmed in the application thromboelastometry, showing pronounced hypocoagulation and a significant reduction in fibrin formation dynamics.
Results. In chronic GBF oral administration to rats at a dose of 25 mg/kg was fixed almost a 10-fold reduction in ADP-induced platelet aggregation, with increased content of these cells in the peripheral blood. Furthermore, in these conditions, there was a pronounced effect of GBF’s hypocoagulation which was implemented in inhibiting reactions inner and outer tracks of blood clotting, reducing the rate of formation of fibrin and its mechanical density.
Conclusion.Thus, in experiments in vitro and in vivo for the first time revealed the ability of isoflavone 7-O-gentiobiozideformononetin extracted from the roots Maackia amurensis, inhibit the processes of vascularplatelet and coagulation hemostasis. This fact is of great practical importance, because it opens the prospective of the development of a new drug that can reduce the risk of thrombosis in various cardiovascular diseases.
About the Authors
Ya. F. ZverevRussian Federation
DM, Рrofessor of the Department Pharmacology, Altai State Medical University, Barnaul, Russian Federation
A. V. Kudinov
Russian Federation
PhD, Аssociate Professor of the Department Pharmacology, Altai State Medical University, Barnaul, Russian Federation
A. P. Momot
Russian Federation
DM, Рrofessor, Altai State Medical University, Physiological Research Institute of SO RAMN, Altai Department, Director of Hematological Research Center, Altai Department, Barnaul, Russian Federation
S. A. Fedoreyev
Russian Federation
DCh, Head of the Laboratory of Chemistry, Natural Quinonoid Compounds, G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch, Russian Academy of Sciences, Vladivostok, Russian Federation
S. V. Zamyatina
Russian Federation
PhD, Аssociate Professor of Biochemistry’s Faculty and Clinical Laboratory Diagnostics, Altai State Medical University, Barnaul, Russian Federation
N. I. Kulesh
Russian Federation
PhD, Senior Researcher of the Laboratory of Chemistry of Natural Quinonoid Compounds, G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch, Russian Academy of Sciences, Vladivostok, Russian Federation
N. A. Lychova
Russian Federation
Graduate of Physiological’s Faculty, Junior Scientific Researcher, Altai State Medical University, Physiological Research Institute SO RAMN, Altai Department, Barnaul, Russian Federation
D. V. Fyodorov
Russian Federation
DM, Head of the Department of Nursing, Altai State Medical University, Barnaul, Russian Federation
References
1. Upadhyay S., Dixit M. Role of polyphenols and other phytochemicals on molecular signaling // Oxid. Med. Cell. Longev. 2015; 504253. doi: /10.1155/2015/504253.Epub. 2015. Jun 9.
2. Novotnyiy Dzh. A. Antotsianinyi, flavonoidyi i serdechno-sosudistyie zabolevaniya [Anthocyanins, flavonoids and cardiovascular disease] // Vopr. Dietol, 2014; 4 (3): 28–31 (in Russian).
3. Vorobeva E.N., Fomicheva M.L., Vorobev R.I. i dr. Alimentarnyie faktoryi riska serdechno-sosudistyih zabolevaniy i ih korrektsiya [Nutritional risk factors for cardiovascular diseases and their correction] // Ateroskleroz – Atherosclerosis, 2015; 1: 68–73 (in Russian).
4. Jacques P.F., Cassidy A., Peterson J.J., Dwyer J.T. Dietary flavonoid intakes and CVD incidence in the Framingham Offspring Cohort // Br. J. Nutr. 2015; 114 (9): 1496 –1503. doi: 10.1017/S0007114515003141. Epub. 2015. Sep 3.
5. Fedoreev S.A., Kulesh N.I., Glebko L.I. et al. Maksar: a preparation based on Amur Maackia // Pharm. Chem. J. 2004; 38: 605–610.
6. Fedoreev S.A., Kulesh N.I., Mischenko N.P. et al. Sredstvo, obladayuschee protivoopuholevoy aktivnostyu [A Means of having anticancer activity]. Patent RF 2414920. Bull. № 9, 27.03. 2011 (in Russian).
7. Plotnikova A.M., Shulgau Z.T., Plotnikova T.M. Antitrombogennaya i antitrombotsitarnaya aktivnost ekstrakta iz drevesinyi Maakii amurskoy [Antithrombogenic and antiplatelet activity of the extract from the wood of Maackia amurensis] // Byull. eksperim. biol. i med – Bull. Experim. Biol. and Med. 2009; 147 (2): 164–167 (in Russian).
8. Kulesh N.I., Fedoreyev S.A., Veselova V.M. et al. Antioxidant Activity of the Isoflavonoids from the Roots of Maackia amurensis // Nat. Prod. Comm. 2013; 8 (5): 589–592.
9. Kushnerova N.F., Fedoreev S.A., Fomenko S.E.et al. Gepatoprotektornyie svoystva izoflavonoidov iz korney Maackia amurensis pri eksperimentalnom porazhenii pecheni chetyirehhloristyim uglerodom [Hepatoprotective properties of isoflavonoids from the roots of Maackia amurensis on experimental liver damage by carbon tetrachloride] // Eksperim. i klin. Farmakol. 2014; 77 (2): 26–30 (in Russian).
10. Zamyatina S.V., Zverev Ya.F., Kulesh N.I., Fedoreev S.A Sredstvo, obladayuschee antiagregantnoy i antikoagulyantnoy aktivnostyu [A Means of having antiplatelet and anticoagulant activity] Patent 2573379 RF. Bull. № 2, 12.08.2016 (in Russian).
11. Barkagan Z.S., Momot A.P. Diagnostika i kontroliruemaya terapiya narusheniy gemostaza. Izdanie 3. [Diagnostics and controlled therapy of disorders of hemostasis. Edition 3]. Moscow, Nyudiamed Publ., 2008: 292 (in Russian).
12. Mamaev A.N., Gilmanov A.Zh., Vavilova T.V., Momot A.P. Preanaliticheskiy etap is-sledovaniya sistemyi gemostaza [The pre-analytical phase of the study of hemostasis system] // Klin. lab. diagnostika. 2011; 4: 35–39 (in Russian).
13. Anischenko A.M. Hemoreological effects of complex isoflavonoid preparation in ovariectomized rats // Bull. Exp. Biol. Med. 2013; 154 (6): 755–757.
14. Fuentes E., Palomo I. Antiplatelet effects of natural bioactive compounds by multiple targets: Food and drug interactions // J. Funct. Foods. 2014; 6: 73–81.
15. Karlíčkova J., Říha M., Filipský T. et al. Antiplatelet effects of flavonoids mediated by inhibition of arachidonic acid based pathway. Published on-line. Planta med © Georg Thieme Verlag KG Stuttgart New York ISSN 0032-0943. doi: 10.1055/s-0035- 1557902.
16. Navarro-Nuсez L., Lozano M.L., Palomo M. et al. Apigenin inhibits platelet adhesion and thrombus formation and synergizes with aspirin in the suppression of the arachidonic acid pathway // J. Agric. Food Chem. 2008; 56(9): 2970–2976. doi: 10.1021/jf0723209. Epub. 2008. Apr 15.
17. Navarro-Nuсez L., Castillo J., Lozano M.L. et al. Thromboxane A2 receptor antagonism by flavonoids: structure- activity relationships // J. Agric. Food Chem. 2009; 57 (4): 1589–1594. doi: 10.1021/jf803041k.
18. Mozzicafreddo M., Cuccioloni M., Eleuteri A.M. et al. Flavonoids inhibit the amidolytic activity of human thrombin // Biochimie. 2006; 88 (9): 1297–1306. Epub. 2006. Apr 27.
19. Bijak M., Saluk J., Ponczek M.B., Nowak P. Antithrombin effect of polyphenol- rich extracts from black chokeberry and grape seeds // Phytother. Rec. 2013; 27 (1): 71–76. doi: 10.1002/ptr.4682. Epub. 2012. Apr 4.
20. Mira A., Alkhiary W., Shimizu K. Antiplatelet and anticoagulant activities of Angelica shikokiana extract and its isolated compounds // Clin. Appl. Thromb. Hemost. 2015: 1– 9. doi: 10.1177/1076029615595879. Epub. 2015. Jul 15.
21. Byishevskiy A.Sh., Umutbaeva M.K., Alborov R.G. Svyaz gemostaza s perekisnyim okis-leniem lipidov [Link of hemostasis with lipid peroxidation]. Moscow: Med. Kniga
22. Publ., 2003: 95 (in Russian).
23. Cuccioloni M., Mozzicafreddo M., Bonfili L. et al. Natural occuring polyphenols as template for drug design. Focus on serine proteases // Chem. Biol. Drug Des. 2009; 74 (1): 1–15. doi: 10.1111/j.1747-0285.2009.00836.x.
24. Gunnarson G.T., Riaz M., Adams J., Desai U.R. Synthesis of per-sulfated flavonoids using 2,2,2-trichloro ethyl protecting group and their factor Xa inhibition potential // Bioorg. Med. Chem. 2005; 13 (5): 1783–1789.
25. Correia-da-Silva M., Susa E., Duarte B. et al. Flavonoids with an oligopolysulfated moiety: a new class of anticoagulant agents // J. Med. Chem. 2011; 54 (1): 95–106. doi: 10.1021/jm1013117. Epub. 2010. Dec 7.
26. Bijak M., Ponczek M.B., Nowak P. Polyphenol compounds belonging to flavonoids inhibit activity of coagulation factor X. Intern // J. Biol. Macromol. 2014; 65: 129–135. doi: 10.1016/j.ijbiomac.2014.01.023. Epub.2014. Jan 18.
27. Cuccioloni M., Mozzicafreddo M., Sparapani L. et al. Pomegranate fruit components modulate human thrombin // Fitoterapia. 2009; 80 (5): 301–305. doi: 10.1016/j.fitote.2009.03.009. Epub. 2009. Apr 7.
28. Pawlaczyk I., Czerchawski L.,Kuliczkowski W. et al. Anticoagulant and anti- platelet of polyphenolic-polysaccharide preparation isolated from the medicinal plant Erigeron canadensis L. // Thromb. Res. 2011; 124 (4): 328–340. doi: 10.1016/j.thromres.2010.11.031. Epub. 2010. Dec 18.
29. Liu L., Ma H., Yang N. et al. A series of natural flavonoids as thrombin inhibitors: structure-activity relationships // Thromb. Res. 2010; 126 (5): e365– e378. doi: 10.1016/j.thromres.2010.08.006. Epub. 2010. Sep 15.
30. Bijak M., Ziewiecki R., Saluk J. et al. Thrombin inhibitory activity of some polyphenolic compounds // Med. Chem. Res. 2014; 23: 2324–2337. Epub. 2013. Oct 16.
Review
For citations:
Zverev Ya.F., Kudinov A.V., Momot A.P., Fedoreyev S.A., Zamyatina S.V., Kulesh N.I., Lychova N.A., Fyodorov D.V. The antiplatelet and anticoagulant activity of 7-O-gentiobiozide formononetin in vitro and in vivo. Bulletin of Siberian Medicine. 2016;15(4):30-39. (In Russ.) https://doi.org/10.20538/1682-0363-2016-4-30-39